Mechanisms contributing to anemia in these patients include deficiency of erythropoietin (EPO), a hormone that is produced in kidneys and to a lesser extent in the liver that supports normal red blood cell production, uremia‐induced inhibition of hematopoiesis, shortened erythrocyte survival, and disordered iron metabolism.1 The gene discussed is EPO; the disease is uremia.